Accuray (Accuray) Accounts Receivable : $77.4 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Accuray Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Accuray's accounts receivables for the quarter that ended in Dec. 2023 was $77.4 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Accuray's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 65.86.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Accuray's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was $-2.22.

Accuray Accounts Receivable Historical Data

The historical data trend for Accuray's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accuray Accounts Receivable Chart

Accuray Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accounts Receivable

Get a 7-Day Free Trial

106.63

78.86

73.01

94.44

74.78

Accuray Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Receivable	Get a 7-Day Free Trial															89.19	77.35	74.78	77.37	77.40

Accuray Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Accuray Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Accuray's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	77.397	/	107.238	*	91
=	65.86

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Accuray's accounts receivable are only considered to be worth 75% of book value:

Accuray's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(72.756	+	0.75 * 77.397	+	0.5 * 155.228	-	428.697
-	0	-	0)	/	99.1639
=	-2.22

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Accuray Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Accuray's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Accuray (Accuray) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accuray Inc (NAS:ARAY) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

XEJ:Germany

Address

1240 Deming Way, Madison, WI, USA, 53717

Website

https://www.accuray.com

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Executives

Gina Corradetti	officer: VP, Corporate Controller	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Ali Pervaiz	officer: SVP Chief Financial Officer	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Jesse Chew	officer: SVP and General Counsel	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Sandeep Chalke	officer: SVP, Chief Commercial Officer	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Suzanne C Winter	officer: SVP & Chief Commercial Officer	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Patrick Spine	officer: SVP, Chief Admin Officer	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Michael Hoge	officer: Senior VP Global Operations	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Robert Kill	director	VIRTUAL RADIOLOGIC CORPORATION, 5995 OPUS PARKWAY, SUITE 200, MINNETONKA MN 55343
Brandon W Green	officer: Chief Financial Officer	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Franco N Palomba	officer: VP, Chief Accounting Officer	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Byron C Scott	director	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Joshua Levine	officer: President & CEO	1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Mika Nishimura	director	471 EL CAMINO REAL, SANTA CLARA CA 95050
Joseph E Whitters	director
Shigeyuki Hamamatsu	officer: VP, Finance and CAO	1875 CHARLESTON ROAD, MOUNTAIN VIEW CA 94043